NA17-A

Known as: NA17 A, NA17-A Antigen, NA17A 
A specific melanoma antigen protein derived from a patient (NA17) with cutaneous melanoma metastases. When administered in a vaccine formulation… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2015
01219972015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Endogenous tumor-specific T cells are detectable in patients with different tumor types including malignant melanoma (MM). They… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
A number of cytotoxic T-cell epitopes are cryptic epitopes generated from non-conventional sources. These include epitopes that… (More)
Is this relevant?
2008
2008
HLA multimers are now widely used to stain and sort CD8 T lymphocytes specific for epitopes from viral or tumoral antigens… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2006
2006
PURPOSE A phase I/II trial was conducted to evaluate clinical and immunologic responses after intralymphatic and intranodal… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
In this study, we investigated the mRNA and protein expression of nine tumour antigens in human glioblastoma multiforme with a… (More)
  • figure 2
  • figure 1
  • figure 3
  • table 1
  • table 2
Is this relevant?
2002
2002
DCs hold promise for cancer immunotherapy due to their functional ambivalence: iDCs internalize antigens, then mDCs trigger naive… (More)
Is this relevant?
1998
1998
Several tumor antigens have been described as candidates for immunotherapy. Our study compared HLA-A2-restricted epitopes from 5… (More)
Is this relevant?
1997
1997
We reported previously that a large fraction of melanoma cell lines induced a suboptimal activation of specific CTL clones… (More)
Is this relevant?